Life Science Nation (LSN) have launched New York City's first Redefining Early Stage Investments (RESI) Conference on November 15th, 2017. RESI NYC will bring together more than 400 fundraising CEOs and nearly 400 early stage investors (a 1:1 ratio) from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.
The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The recent RESI Conference in San Francisco had nearly 1000 registrants and a full partnering floor. Through the RESI Partnering, fundraising executives can have up to 16 scheduled meetings as well as many more ad-hoc meetings with diverse life science investors who fit their company’s technology sector, indication and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates.
FOR INVESTORS: Due to the popularity of the RESI conference and capacity of the venue, please contact research@lifesciencenation.com to request a complimentary investor code, if available.
*Limit of 2 registrations per investment organization.
Cancellation Policy: All cancellations must be made in writing via e-mail 30 days prior to the conference date to receive a refund. All refunds will incur a $250 administrative fee and will be processed in the original form of payment. No refunds will be issued beyond the 30-day window. Registrations may be transferred to a replacement from your company if registrant is unable to attend. Please email all cancelation requests to RESI@LifeScienceNation.com